Australia markets open in 6 hours 4 minutes

InnoCare Pharma Limited (INCPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.2600-0.4600 (-12.37%)
As of 09:41AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
738,537
738,537
625,404
1,043,033
1,364
-
Cost of revenue
128,435
128,435
143,397
65,667
0
-
Gross profit
610,102
610,102
482,007
977,366
1,364
-
Operating expenses
Research development
751,176
751,176
639,139
721,584
402,771
-
Selling general and administrative
252,126
252,126
309,549
343,268
113,149
-
Total operating expenses
1,259,815
1,259,815
1,213,147
1,143,605
495,911
-
Operating income or loss
-649,713
-649,713
-731,140
-166,239
-494,547
-
Interest expense
35,031
35,031
17,045
2,642
1,139
-
Income before tax
-644,206
-644,206
-893,727
-20,121
-391,865
-
Income tax expense
1,426
1,426
0
46,558
0
-
Income from continuing operations
-645,632
-645,632
-893,727
-66,679
-391,865
-
Net income
-631,263
-631,263
-886,593
-64,545
-391,395
-
Net income available to common shareholders
-631,263
-631,263
-886,593
-64,545
-391,395
-
Basic EPS
-0.32
-
-0.60
-0.05
-0.40
-1.71
Diluted EPS
-0.32
-
-0.60
-0.05
-0.40
-1.71
Basic average shares
1,704,282
-
1,479,565
1,366,261
967,576
1,251,617
Diluted average shares
1,704,282
-
1,479,565
1,366,261
967,576
1,251,617